Endotronix, Inc.: Endotronix Extends Positive Outcomes with 12-month Data Release from the SIRONA 2 Trial for Remote Heart Failure Management Using the Cordella Pulmonary Artery Sensor

The study met secondary study endpoints and long-term sensor use was associated with significant improvements in patient quality-of-life metrics and low event rates for heart failure hospitalization

Related Keywords

New York ,United States ,Germany ,Giessen ,Hessen ,Harry Rowland ,Gewinn Nur ,Swan Ganz ,Medtech Digital Health ,University Of Giessen ,Prnewswire Endotronix Inc ,European Society Of Cardiology ,Cordella Pulmonary Artery ,New York Heart Failure ,European Society ,Heart Failure ,Professor Birgit ,Digital Health ,Cordella Sensor ,Endotronix ,Xtends ,Positive ,Outcomes ,Month ,Data ,Release ,Rom ,Sirona ,Trial ,Remote ,Heart ,Failure ,Management ,Sing ,Cordella ,Pulmonary ,Artery ,Sensor ,